TFF GROUP news, videos and press releases
For more news please use our advanced search feature.
TFF GROUP - More news...
TFF GROUP - More news...
- TFF Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
- TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program for U.S. Warfighters
- TFF Pharmaceuticals Prices Offering of Common Stock
- TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business Results
- NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
- NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
- Feasibility Arrangement for Shelf-stable Powder Form of Messenger RNA COVID-19 Vaccine Candidate Announced by GreenLight Biosciences and TFF Pharmaceuticals
- Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF Pharmaceuticals
- Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF Pharmaceuticals
- TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021
- TFF Pharmaceuticals Provides Update on Clinical Development Programs
- TFF Pharmaceuticals to Present at the BIO CEO & Investor Digital Conference
- TFF Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
- TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation Powder in a Phase 1b Clinical Trial
- TFF Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
- TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results
- TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License Agreement
- TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies
- TFF Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020
- TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza Vaccines
- TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with Experic
- TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder
- TFF Pharmaceuticals Announces Results of Its 2020 Annual Meeting of Stockholders
- IRISYS LLC Signs a Third Contract with TFF Pharma to Produce Medication to Treat Lung Conditions, Including COVID-19
- TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
- TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial
- TFF Pharmaceuticals to Participate in Anti-fungal Webinar Presented by Maxim Group LLC on September 17th, 2020
- TFF Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
- TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film Freezing Technology in Combination with niclosamide
- TFF Pharmaceuticals Reports Second Quarter 2020 Financial and Business Results
